Bencard Adjuvant Systems is a division of Allergy Therapeutics UK; a fully integrated,
speciality pharmaceutical company. Allergy Therapeutics plc is listed on the London Stock
Exchange; AIM ticker AGY.
Located in Worthing, on England’s south coast, Bencard Adjuvant Systems specialise in
developing and optimising adjuvants for infectious diseases, cancer immunotherapy and
We at Bencard Adjuvant Systems are committed to engaging in long-term partnerships with
those who require our patented platform of adjuvant technologies to enable successful
vaccine or immunotherapy development.